Journal · Cell death · Updated 22 November 2026
Apoptosis
Read Apoptosis articles on DeepDyve. No university library needed.
Apoptosis has published since 1996 and covers how cells die, from apoptosis and autophagy to newer forms of regulated cell death such as ferroptosis and cuproptosis, and how these processes shape cancer, tumor immunity and diseases such as osteoarthritis. Springer Nature publishes it. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Apoptosis at a glance
- Full title
- Apoptosis
- Abbreviation (NLM)
- Apoptosis
- Publisher
- Springer Nature
- Print ISSN
- 1360-8185
- Online ISSN (eISSN)
- 1573-675X
- First published
- 1996
- Subjects
- Cell Biology
- Access model
- Hybrid (16% free to read in 2026)
Ways to access Apoptosis
16% of the articles Apoptosis published from January 1 to November 20, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 16% of Apoptosis articles published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Apoptosis. Check its journal list and whether it offers remote access.
- DeepDyve. Read Apoptosis articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Apoptosis’ 2025 Journal Impact Factor is 9.0, and its 5-year Impact Factor is 9.2.
9.0
Journal Impact Factor (2025)
9.2
5-year Impact Factor (2025)
7 days
Median time to first decision
Source: journal metrics on the Apoptosis homepage (Springer Nature), checked November 22, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Apoptosis research worth reading
Published January to May 2026. Summaries describe what the authors report.
-
PSD3 links autophagic flux to MHC-I–associated immune modulation in esophageal squamous cell carcinoma
In esophageal squamous cell carcinoma, the authors report that PSD3 is upregulated and tied to poor prognosis, and that knocking it down impaired autophagic flux, raised total MHC-I protein levels and was linked to greater immune cell infiltration in mouse tumor models.
Luo et al. · Apoptosis, published online May 18, 2026 · DOI 10.1007/s10495-026-02345-8
-
Looking at the fraction with Annexin V⁺ and propidium iodide⁺: insights into cell death types from preclinical studies in solid and haematological cancers
In a review of preclinical cancer studies, the authors argue that cells positive for both Annexin V and propidium iodide may be undergoing several kinds of regulated cell death, not just late apoptosis, and are better labeled late-stage cell death without molecular or microscopy data.
Hassan et al. · Apoptosis, published online March 11, 2026 · DOI 10.1007/s10495-026-02261-x
-
Harnessing Cuproptosis resistance to advance cancer therapeutics
In a review, the authors describe how cells regulate copper, compare cuproptosis with other forms of immunogenic cell death, discuss how cancer cells come to resist it, and outline nanomedicine strategies aimed at making tumors more sensitive to it.
Li et al. · Apoptosis, published online January 19, 2026 · DOI 10.1007/s10495-026-02266-6
-
Programmed cell death in osteoarthritis
In a review, the authors describe the molecular basis of seven forms of programmed cell death, including apoptosis, pyroptosis, ferroptosis and PANoptosis, and how they regulate the survival and death of chondrocytes in the onset and progression of osteoarthritis.
Li et al. · Apoptosis, published online January 9, 2026 · DOI 10.1007/s10495-025-02210-0
-
Interaction of HIF-1a with various cell death pathways in tumor immune microenvironment (TIME)
In a systematic review of 70 studies, the authors report that HIF-1α helps tumors escape the immune system by promoting immunosuppressive elements of the tumor immune microenvironment and inhibiting apoptosis, while modulating pyroptosis and ferroptosis depending on context.
Varkiani et al. · Apoptosis, published online March 11, 2026 · DOI 10.1007/s10495-025-02249-z
Related journals
Questions about Apoptosis
How can I read Apoptosis articles without a subscription?
16% of Apoptosis articles published from January 1 to November 20, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Apoptosis articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Apoptosis?
Apoptosis isn’t abbreviated: its NLM (PubMed) abbreviation is simply Apoptosis.
What is the ISSN of Apoptosis?
The print ISSN is 1360-8185 and the online ISSN is 1573-675X.
What is the impact factor of Apoptosis?
Apoptosis’ Journal Impact Factor is 9.0 (2025), and its 5-year Impact Factor is 9.2, according to Springer Nature’s published metrics.
Is Apoptosis open access?
Apoptosis is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 20, 2026, 41 of 264 Apoptosis articles (16%) carry a Creative Commons license, per Crossref.
Apoptosis articles on DeepDyve are licensed from Springer Nature. Journal facts as of 22 November 2026.
Start reading Apoptosis today
One month free, then less than $2 a day. Apoptosis, plus millions of articles from thousands of journals.






